Novo Nordisk, the manufacturer of both, recently shared that CagriSema may lead to 10 percent more weight loss than Wegovy. Here's what we know so far about this promising new option for those ...

“We should be moving away from a simplistic percent weight loss as the sole obesity treatment target in research, despite its ease of use and measurement, and move towards more comprehensive ...

The weight loss drug Zepbound (tirzepatide) led to 50 percent more weight loss in a 72-week trial than Wegovy (semaglutide). Participants taking Zepbound lost 50 pounds (lb) on average, compared ...

For glycemic control, individuals in this weight loss range experienced an average reduction in hemoglobin A1c of 0.33 percentage points, a clinically relevant improvement that helps lower the ...

Losing just 10 percent of your body weight (that’s 18 pounds if you weigh 180) may help you sleep more soundly. Sleep-disordered breathing, or sleep apnea, in which you momentarily ...